Antibody

7개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved7 programs
AntibodyCurated CoreFDANovo NordiskApproved

semaglutide (Ozempic / Wegovy, GLP-1, Wegovy, NN9535)

Type 2 diabetes, chronic weight management, CV risk reduction (T2D) · GLP-1 receptor

#GLP-1receptor#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 410Status Approved
AntibodyCurated CoreFDAEli LillyApproved

tirzepatide (Mounjaro / Zepbound, Mounjaro, Zepbound, LY3298176)

Type 2 diabetes, chronic weight management · GLP-1 / GIP receptor

#GLP-1GIPreceptor#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 269Status Approved
AntibodyLimited DatastaleNovartisApproved

Basiliximab (Basiliximab)

Type 1 Diabetes Mellitus · Extranodal NK/T-cell Lymphoma

#ExtranodalNKT-cellLymphoma#Antibody#Approved#Popular#monoclonal-antibody+2
Trials 58Status Active
AntibodyLimited DatastaleRochePhase 2

rituximab (Anti-CD20, Anti-CD20 (rituximab))

Presymptomatic Diabetes Type 1 (Stage 1); Diabetes Mellitus, Type I · CD20

#CD20#Antibody#Phase2#monoclonal-antibody#PresymptomaticDiabetesType1Stage+3
Trials 2Status Active
AntibodyLimited DatastaleHoffmann-La RocheApproved

Daclizumab (Daclizumab)

Type 1 Diabetes Mellitus · Myelodysplastic Syndromes

#MyelodysplasticSyndromes#Antibody#Approved#monoclonal-antibody#Type1DiabetesMellitus+1
Trials 2Status Active
AntibodyLimited DatastaleUniversitair Ziekenhuis BrusselPhase 2

ATG-Rituximab-MMF-TAC (ATG-Rituximab-MMF-TAC)

Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 1

#DiabetesMellitusType1#Antibody#Phase2#monoclonal-antibody#DiabetesMellitus+2
Trials 1Status Active
AntibodyLimited DatastaleUniversitair Ziekenhuis BrusselPhase 2

ATG-basilixumab-MMF-TAC (ATG-basilixumab-MMF-TAC)

Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 1

#DiabetesMellitusType1#Antibody#Phase2#monoclonal-antibody#DiabetesMellitus+2
Trials 1Status Active